Indeed, elevated levels of CTNND1 in the nucleus have been observed in E-cadherin-deficient cancer cells [36, 37], indicating a potential role for nuclear CTNND1 in enhancing the metastatic phenotype associated with E-cadherin downregulation [37]. Here, CTNND1 is linked to cancer.